Instil Bio, Inc. (TIL)
7.15
+0.01
(+0.14%)
USD |
NASDAQ |
Sep 30, 16:00
7.15
0.00 (0.00%)
After-Hours: 18:31
Instil Bio Price : 7.15 for Sept. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 29, 2026 | 7.04 | 7.23 | 7.04 | 7.14 | 4130.00 |
| Sep 28, 2026 | 7.115 | 7.16 | 7.03 | 7.04 | 11568.00 |
| Sep 25, 2026 | 7.05 | 7.17 | 7.05 | 7.17 | 9505.00 |
| Sep 24, 2026 | 7.14 | 7.24 | 7.05 | 7.12 | 8362.00 |
| Sep 23, 2026 | 7.030 | 7.38 | 7.030 | 7.235 | 11584.00 |
| Sep 22, 2026 | 7.02 | 7.20 | 7.00 | 7.13 | 23894.00 |
| Sep 21, 2026 | 7.09 | 7.20 | 6.92 | 7.07 | 69053.00 |
| Sep 18, 2026 | 7.13 | 7.21 | 7.08 | 7.09 | 27516.00 |
| Sep 17, 2026 | 7.305 | 7.399 | 7.10 | 7.21 | 11683.00 |
| Sep 16, 2026 | 7.29 | 7.29 | 7.16 | 7.18 | 8532.00 |
| Sep 15, 2026 | 7.46 | 7.46 | 7.21 | 7.21 | 17342.00 |
| Sep 14, 2026 | 7.36 | 7.64 | 7.36 | 7.45 | 22441.00 |
| Sep 11, 2026 | 7.32 | 7.67 | 7.32 | 7.38 | 33973.00 |
| Sep 10, 2026 | 7.54 | 7.70 | 7.36 | 7.36 | 11375.00 |
| Sep 09, 2026 | 7.66 | 7.70 | 7.50 | 7.58 | 7839.00 |
| Sep 08, 2026 | 7.58 | 7.82 | 7.50 | 7.82 | 6281.00 |
| Sep 04, 2026 | 7.59 | 7.64 | 7.58 | 7.58 | 3011.00 |
| Sep 03, 2026 | 7.71 | 7.78 | 7.584 | 7.66 | 6456.00 |
| Sep 02, 2026 | 7.73 | 7.79 | 7.67 | 7.685 | 3883.00 |
| Sep 01, 2026 | 7.71 | 7.81 | 7.59 | 7.69 | 11900.00 |
| Aug 31, 2026 | 7.56 | 7.69 | 7.54 | 7.61 | 2601.00 |
| Aug 28, 2026 | 7.79 | 7.83 | 7.450 | 7.58 | 14491.00 |
| Aug 27, 2026 | 7.685 | 7.875 | 7.600 | 7.86 | 8285.00 |
| Aug 26, 2026 | 7.745 | 7.89 | 7.62 | 7.83 | 10692.00 |
| Aug 25, 2026 | 7.75 | 7.88 | 7.60 | 7.60 | 5378.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.14 |
| Alnylam Pharmaceuticals, Inc. | 246.82 |
| Anika Therapeutics, Inc. | 19.67 |
| Savara, Inc. | 5.15 |
| Vericel Corp. | 40.12 |
Price Related Metrics
| Price to Book Value | 0.4516 |
| Earnings Yield | -62.55% |
| Market Cap | 48.49M |